You may also like
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19
The present findings suggested that about half of adult patients with severe COVID-19–related ARDS can be managed successfully with ECMO with sustained results at six months. Decreased arterial pH before ECMO was associated significantly with early mortality. Therefore, the authors hypothesized that initiation of ECMO therapy before severe metabolic derangements subset may improve survival rates significantly in these patients. These results should be viewed in the light of a strict patient selection policy and may not be replicated in patients with advanced age or multiple comorbidities.
Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016
Significant changes were found in the characteristics of patients undergoing PCI and CABG in the United States between 2003 and 2016. Risk-adjusted mortality decreased significantly after CABG but not after PCI across all clinical indications.
Pro/Con: Component Therapy is Better than Fresh Whole Blood (EP Video)
John St. Onge discusses the age old debate of component therapy vs. fresh whole blood (9:19 minutes).